Be the first to like this
Great potential for innovation and impact on patient outcomes in personalized medicine lies in theranostics according to personal medicine pioneer Gualberto Ruano. Ruano spoke at CVG’s Venture Connection program at UConn’s Business School in Hartford earlier this month. He sees the prime opportunity for innovation in the translation of Biomedics into clinical practice. Greg Zaic, principal at NMT Capital spoke about the development of pharma into very individualized treatments He foresees our children receiving very specific, highly successful therapies. However, the cost of research and development for all those solutions to disease management when before there were only a few options will be very expensive.